Literature DB >> 17303016

Is it always necessary to treat a ureteropelvic junction syndrome?

Paul J Van Cangh1.   

Abstract

The term ureteropelvic junction (UPJ) obstruction covers different morbid entities, and the old aphorism, "A UPJ is not a UPJ" remains true. Hydronephrosis is readily seen on antenatal ultrasonography but does not necessarily imply obstruction. Although most cases will resolve spontaneously, the probability of a significant pathology is related to the degree of pyelectasis, as seen on the third trimester study. Criteria of obstruction are difficult to define with precision, but two that are well-accepted are size of the renal pelvis (> 15 mm) and relative renal function, as determined by adequate isotopic studies. A new therapeutic standard has been established, and minimally invasive surgery has finally dethroned its open rival. Possibly facilitated by robotic assistance, laparoscopic dismembered pyeloplasty is the present gold standard, albeit endopyelotomy remains the least invasive with similar results in carefully selected patients.

Entities:  

Mesh:

Year:  2007        PMID: 17303016     DOI: 10.1007/s11934-007-0060-2

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  24 in total

Review 1.  Minimally invasive surgery for pelviureteral junction obstruction in adults: a critical review of the options.

Authors:  R Manikandan; A Saad; R I Bhatt; D Neilson
Journal:  Urology       Date:  2005-03       Impact factor: 2.649

2.  Laparoscopic pyeloplasty: evolution of a new gold standard.

Authors:  D A Moon; M A El-Shazly; C M Chang; T R Gianduzzo; C G Eden
Journal:  Urology       Date:  2006-04-25       Impact factor: 2.649

3.  Prospective, randomized comparison of ureteroscopic endopyelotomy using holmium:YAG laser and balloon catheter.

Authors:  Ahmed R el-Nahas; Ahmed M Shoma; Ibrahim Eraky; Mahmoud R el-Kenawy; Hamdy A el-Kappany
Journal:  J Urol       Date:  2006-02       Impact factor: 7.450

4.  Antegrade versus retrograde endopyelotomy for pelvi-ureteric junction (PUJ) obstruction.

Authors:  Andrea Minervini; Kim Davenport; Francis X Keeley; Anthony G Timoney
Journal:  Eur Urol       Date:  2005-12-28       Impact factor: 20.096

5.  The magnitude of fetal renal pelvic dilatation can identify obstructive postnatal hydronephrosis, and direct postnatal evaluation and management.

Authors:  Douglas E Coplen; Paul F Austin; Yan Yan; Valerie M Blanco; Jeffrey M Dicke
Journal:  J Urol       Date:  2006-08       Impact factor: 7.450

6.  Retrospective comparison of retroperitoneal laparoscopic versus open dismembered pyeloplasty for ureteropelvic junction obstruction.

Authors:  Xu Zhang; Hong-Zhao Li; Xin Ma; Tao Zheng; Bin Lang; Jun Zhang; Bin Fu; Kai Xu; Xiao-Lin Guo
Journal:  J Urol       Date:  2006-09       Impact factor: 7.450

7.  Prenatal ultrasound has led to earlier detection and repair of ureteropelvic junction obstruction.

Authors:  Seth A Capello; Barry A Kogan; Louis J Giorgi; Ronald P Kaufman
Journal:  J Urol       Date:  2005-10       Impact factor: 7.450

Review 8.  Congenital unilateral hydronephrosis: a review of the impact of diuretic renography on clinical treatment.

Authors:  Anni Eskild-Jensen; Isky Gordon; Amy Piepsz; Jørgen Frøkiaer
Journal:  J Urol       Date:  2005-05       Impact factor: 7.450

9.  Prediction of differential creatinine clearance in chronically obstructed kidneys by non-contrast helical computerized tomography.

Authors:  C F Ng; L W Chan; K T Wong; C W Cheng; S C H Yu; W S Wong
Journal:  Int Braz J Urol       Date:  2004 Mar-Apr       Impact factor: 1.541

10.  Ureteropelvic junction obstruction in children: two variants of the same congenital anomaly?

Authors:  Luis H P Braga; Agnes Liard; Bruno Bachy; Paul Mitrofanoff
Journal:  Int Braz J Urol       Date:  2003 Nov-Dec       Impact factor: 1.541

View more
  1 in total

1.  Evaluation of Caspase 3 Enzyme and TNF-alpha as Biomarkers in Ureteropelvic Junction Obstruction in Children- a preliminary report.

Authors:  Mehdi Shirazi; Ali Eslahi; Vahidreza Sharifi; Fatemeh Rahimi; Alireza Safarpour
Journal:  Pak J Med Sci       Date:  2017 Mar-Apr       Impact factor: 1.088

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.